ClearPoint Neuro

CLPT

----

Current ValuationThe current P/E ratio is -8.40, within the reasonable range, cheaper than 20.41% of the time in the past 5 years, and the industry ranks 128/174, the industry Median -0.76.

-8.4xP/E

Stock price$9.95Earnings per share$-1.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GKOSUSGlaukos	-82.89x	90.98%	$14.07B
BAXUSBaxter	-17.32x	163.21%	$12.52B
TFXUSTeleflex	-5.78x	118.39%	$5.96B
IRTCUSIRhythm	-298.20x	53.96%	$4.16B
PLSEUSPulse Biosciences	-47.13x	26.85%	$3.77B
AXGNUSAxogen	-91.62x	12.42%	$2.92B
ASSTUSStrive	-2.65x	57.99%	$2.58B
KMTSUSKestra Medical Tech	-11.66x	0.79%	$1.75B
BFLYUSButterfly Network	-30.45x	36.13%	$1.63B
NVCRUSNovocure	-12.64x	14.26%	$1.54B
TNDMUSTandem Diabetes	-20.52x	77.60%	$1.30B
ENOVUSEnovis	-1.08x	100.97%	$1.19B
DRTSUSAlpha Tau Medical	-12.80x	--	$1.18B
AORTUSArtivion	-360.29x	266.67%	$1.15B
ATECUSAlphatec	-12.99x	51.04%	$1.13B
PRCTUSPROCEPT BioRobotics	-10.14x	3.47%	$1.11B
CBLLUSCeribell	-15.68x	35.19%	$1.03B
QDELUSQuidelOrtho	-0.92x	75.33%	$962.11M
SIBNUSSI-BONE	-61.93x	8.85%	$906.23M
BBNXUSBeta Bionics	-10.07x	13.02%	$837.01M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.